Press Release-Yaohai Biopharmaceutical Co., Ltd.

Press Release

Yaohai Bio-Pharma and Topgene Bio Establish Strategic Partnership

Mar 27, 2025

March 19, 2025 – Yaohai Biopharmaceutical Co., Ltd. (Yaohai Bio-Pharma) and Hubei Topgene Biotechnology Group Co., Ltd. (Topgene Bio) have officially entered a strategic partnership, marking a significant step toward advancing biopharmaceutical...

Breakthrough Drug pUDK HGF: Light for Lower Limb Ischemia Patients
Dec 06, 2024
Good news! Humanwell Healthcare and Yaohai Bio-Pharma jointly submitted a BLA for pUDK HGF On December 4th, according to the CDE website, Humanwell Healthcare and Yaohai Bio-Pharma jointly submitted a biologics license application (BLA) for pUDK hepa...
Read More
Congratulations to Yaohai’s CDMO Client
Aug 15, 2024
Good news! Northland Biotech's Naked Plasmid NL003 BLA was accepted by NMPA On July 16 2024, the valued client of Yaohai Bio-Pharma, Beijing Northland Biotechnology Co., Ltd. (Northland), announced that its independently developed Category 1 new th...
Read More
Yaohai Bio-Pharma Passed EU QP Audit and Attains ISO Triple Certification
May 08, 2024
Good news! Yaohai Bio-Pharma has recently passed the on-site audit by the European Union Qualified Person (QP) for the GMP quality system and production site. Additionally, it has cleared the initial certification audits for ISO9001 Quality Managemen...
Read More